Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction.
View / Open Files
Authors
Senanayake, Russell
MacFarlane, James
van der Meulen, Merel
Koulouri, Olympia
Powlson, Andrew S
Crawford, Rosy
Gillett, Bethany
Bird, Nick
Heard, Sarah
Kolias, Angelos
Mannion, Richard
Aloj, Luigi
Mendichovszky, Iosif A
Cheow, Heok
Bashari, Waiel A
Publication Date
2022-05-07Journal Title
EJNMMI Res
ISSN
2191-219X
Publisher
Springer Science and Business Media LLC
Volume
12
Issue
1
Language
eng
Type
Article
This Version
VoR
Metadata
Show full item recordCitation
Gillett, D., Senanayake, R., MacFarlane, J., van der Meulen, M., Koulouri, O., Powlson, A. S., Crawford, R., et al. (2022). Localization of TSH-secreting pituitary adenoma using 11C-methionine image subtraction.. EJNMMI Res, 12 (1) https://doi.org/10.1186/s13550-022-00899-7
Abstract
BACKGROUND: Pituitary adenomas (PA) affect ~ 1:1200 of the population and can cause a wide range of symptoms due to hormone over-secretion, loss of normal pituitary gland function and/or compression of visual pathways, resulting in significantly impaired quality of life. Surgery is potentially curative if the location of the adenoma can be determined. However, standard structural (anatomical) imaging, in the form of MRI, is unable to locate all tumors, especially microadenomas (< 1 cm diameter). In such cases, functional imaging [11C-methionine PET/CT (Met-PET)] can facilitate tumor detection, although may be inconclusive when the adenoma is less metabolically active. We, therefore, explored whether subtraction imaging, comparing findings between two Met-PET scans with medical therapy-induced suppression of tumor activity in the intervening period, could increase confidence in adenoma localization. In addition, we assessed whether normalization to a reference region improved consistency of pituitary gland signal in healthy volunteers who underwent two Met-PET scans without medical suppression. RESULTS: We found that the mean percentage differences in maximum pituitary uptake between two Met-PET scans in healthy volunteers were 2.4% for (SUVr) [cerebellum], 8.8% for SUVr [pons], 5.2% for SUVr [gray matter] and 23.1% for the SUVbw [no region]. Laterality, as measured by contrast-noise ratio (CNR), indicated the correct location of the adenoma in all three image types with mean CNR values of 6.2, 8.1 and 11.1 for SUVbw, SUVbwSub and SUVrSub [cerebellum], respectively. Subtraction imaging improved CNR in 60% and 100% of patients when using images generated from SUVbw [no region] and SUVr [cerebellum] scans compared to standard clinical SUVbw imaging. CONCLUSIONS: Met-PET scans should be normalized to the cerebellum to minimize the effects of physiological variation in pituitary gland uptake of 11C-methionine, especially when comparing serial imaging. Subtraction imaging following endocrine suppression of tumor function improved lateralization of PA when compared with single time point clinical Met-PET but, importantly, only if the images were normalized to the cerebellum prior to subtraction.
Keywords
11C-methionine PET, Human pituitary tumors, Normalization, Subtraction imaging
Sponsorship
National Institute for Health Research (IS-BRC-1215-20014)
Identifiers
35524902, PMC9079199
External DOI: https://doi.org/10.1186/s13550-022-00899-7
This record's URL: https://www.repository.cam.ac.uk/handle/1810/337899
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk